Journal of Neurological Surgery Part B: Skull Base

LinksSchließen

Referenz

Lok SW, Whittle JR, Vaillant F. et al.
A phase Ib dose-escalation and expansion study of the BCL2 inhibitor venetoclax combined with tamoxifen in ER and BCL2-positive metastatic breast cancer.

Cancer Discov 2019;
9 (03) 354-369

Bibliographische Angaben herunterladen

Aufrufen in: